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Abstract
Background: A paucity of information on biological sex-specific differences in cardiac gene expression in response
to diet has prompted this present nutrigenomics investigation.
Sexual dimorphism exists in the physiological and transcriptional response to diet, particularly in response to high-
fat feeding. Consumption of Trans-fatty acids (TFA) has been linked to substantially increased risk of heart disease,
in which sexual dimorphism is apparent, with males suffering a higher disease rate. Impairment of the
cardiovascular system has been noted in animals exposed to Monosodium Glutamate (MSG) during the neonatal
period, and sexual dimorphism in the growth axis of MSG-treated animals has previously been noted. Processed
foods may contain both TFA and MSG.
Methods: We examined physiological differences and changes in gene expression in response to TFA and/or MSG
consumption compared to a control diet, in male and female C57BL/6J mice.
Results: Heart and % body weight increases were greater in TFA-fed mice, who also exhibited dyslipidemia
(P < 0.05). Hearts from MSG-fed females weighed less than males (P < 0.05). 2-factor ANOVA indicated that
the TFA diet induced over twice as many cardiac differentially expressed genes (DEGs) in males compared
to females (P < 0.001); and 4 times as many male DEGs were downregulated including Gata4, Mef2d and
Srebf2. Enrichment of functional Gene Ontology (GO) categories were related to transcription,
phosphorylation and anatomic structure (P < 0.01). A number of genes were upregulated in males and
downregulated in females, including pro-apoptotic histone deacetylase-2 (HDAC2). Sexual dimorphism was
also observed in cardiac transcription from MSG-fed animals, with both sexes upregulating approximately
100 DEGs exhibiting sex-specific differences in GO categories. A comparison of cardiac gene expression
between all diet combinations together identified a subset of 111 DEGs significant only in males, 64 DEGs
significant in females only, and 74 transcripts identified as differentially expressed in response to dietary
manipulation in both sexes.
Conclusion: Our model identified major changes in the cardiac transcriptional profile of TFA and/or MSG-fed mice
compared to controls, which was reflected by significant differences in the physiological profile within the 4 diet
groups. Identification of sexual dimorphism in cardiac transcription may provide the basis for sex-specific medicine
in the future.
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There is growing evidence that sexual dimorphism exists
in the physiological response to diet and other environ-
mental factors [1], including differences in insulin and
leptin sensitivity [2,3], particularly in response to high fat
diets [4]. The heart requires high levels of ATP in order
to maintain contractility, and this essential energy
requirement is usually met by the oxidation of fatty acids
(FAs), which are the most important source of energy for
the adult heart. FAs have also been shown to be involved
in signal transduction and the regulation of gene tran-
scription [5]; however excessive FA uptake may cause
detrimental lipotoxicity, resulting in deregulated cardiac
function [6]. Several key studies have recently shown that
considerable sex-dimorphism exists in both rodents and
humans [7]; and have established sex-specific pathways
in cardiac transcription in response to both pressure
overload [8] and dilated cardiomyopathy [9].However
there is a relative scarcity of information concerning sex-
specific effects of diet on cardiac gene expression.
Dietary intake of added fats and oils has increased by
over 60% during the past 35 years [10], and use of
hydrogenated oils and shortenings in order to prolong
shelf-life has resulted in an increase in trans fatty acid
(TFA) consumption, which now accounts for between
1.7 - 8% of the global dietary fat intake (0.6 - 3% of total
energy intake) [11]. TFA consumption has been linked
to the increased risk of obesity [11], inflammation [12],
coronary heart disease (CHD) [13] and type 2 diabetes
[14]. Unlike saturated fat, food nutrition labeling does
not set a recommended intake limit for Trans-fat, how-
ever one meta-analysis study found that a 2% increase
in energy intake from TFA was associated with a 23%
increase in the incidence of CHD [15]. Concern over
the deleterious effects of dietary Trans-fat has prompted
several countries to regulate the industrial production
[16]; and retrospective meta-analysis of observational
controlled dietary trials and prospective cohort studies
suggests that replacement of Trans-fat with nonhydroge-
nated oils would result in significant reduction of the
incidence of CHD [17]. Gender differences in the preva-
lence of CHD are well documented [18], and many fac-
tors appear to be responsible including lipid profile [19]
and genetic susceptibility [20].
Neonatal administration of high doses of the food fla-
vor enhancer Monosodium Glutamate (MSG) has also
been shown to result in obesity [21] together with
stunted heart growth and hypoplasticity in rodents [22].
Furthermore, the cardiovascular system of these animals
have been shown to respond deficiently to certain chal-
lenges, including an attenuated blood pressure response
to the systemic injection of nitric oxide synthase inhibi-
tors, angiotensin II and other vasoactive compounds
[23]. Injections of high doses of MSG (4 g/Kg body
weight) cause ablation of the Arcuate Nucleus via gluta-
mate-induced degeneration of those areas of the imma-
ture brain which are insufficiently protected by a mature
blood-brain barrier, including the hypothalamic area
[24]. This suggested that the hypothalamus may play an
important role in the growth of the heart. It is now
apparent that maternal administration of MSG can
penetrate the placental barrier and distribute to the
embryonic tissues of the fetus. Oral administration of
MSG and
3H-labeled Glutamate (
3H- Glu) as a tracer to
pregnant mice resulted in marked elevations of
3H- Glu
in the placenta and in fetal brain, liver and kidney [25].
MSG consumption has increased globally in recent
years, with recent estimations of the current average
daily intake believed to be up to 10 g/day [26]. Despite
the widespread consumption of this common food flavor
enhancer, which often occurs in processed and packaged
foods in combination with Trans-fat, very few studies
have addressed the effect of dietary Trans-fat and/or
MSG consumption on cardiac gene expression. Further-
more, although sexual dimorphism at the growth hor-
mone axis has been demonstrated in MSG-treated
rodents [27], little is known about sex-specific gene
expression in response to exposure to MSG.
The aim of this work was to establish the effect of
dietary TFA and/or MSG on cardiac gene expression in
an in vivo animal model, and to examine sex-specific
differences as well as commonalities of gene expression
in response to diet. The amount of oral MSG used in
this study reflects current consumption levels [26,28]
and is 30 - 40 times less that the level previously
reported to induce neuronal damage when injected neo-
natally [21,23]. Since it has previously been ascertained
that MSG excitotoxicity occurs only when the blood
brain barrier is vulnerable, for example neonatally
[24,25], and because developmental programming of
cardiac gene expression may be affected by maternal
nutritional balance [29], we bred our study animals
from females previously established on these diets for 3
weeks prior to mating, in accordance with our previous
studies [30]. Exposure to these diets occurred through-
out the study, in order to mimic as closely as possible
the situation that occurs in humans. The results of our
microarray analysis revealed considerable sexual
dimorphism in response to the dietary interventions that
we tested, with males appearing to exhibit more differ-
ential gene expression compared to females.
Results
Consumption of Trans-fat and/or MSG results in sex-
specific changes in physiological characteristics
Figure 1A shows our experimental design and microar-
ray analysis. There were no significant differences in
food and water intake between the 4 different diet
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Page 2 of 15groups or between the sexes (data not shown). Averaged
daily MSG intake was 91.21 ± 4.63 and 99.04 ± 2.5 mg/
Kg body weight in males and females respectively.
Trans-fat (TFA) feeding resulted in elevated weight gain
(6-32 weeks) and greater heart weights in both sexes
(Table 1, P < 0.001), and females weighed less than
males (P ≤ 0.05). Additionally, male mice in the MSG
and Trans-fat diet groups had significantly greater
weight gain and heart : body weight ratios compared to
females (P < 0.001). Analysis of significant sex-specific
differences in response to diet indicated that females in
the MSG and the MSG+TFA diet group had smaller
hearts and lower fasting HDL-C levels compared to
males. Females in the TFA diet group also had higher
fasting triglyceride and HOMA-IR values compared to
female control diet mice. Conversely TFA feeding ele-
vated male T-CHOL and HDL-C levels. There was no
apparent difference in the histological appearance of
cardiac tissues from the four diet groups (online Addi-
tional File 1).
Sexual dimorphism in cardiac gene expression
We used Affymetrix Mouse Gene 1.0 ST expression
arrays to determine differences in global cardiac gene/
Expressed Sequence Tags (ESTs) in response to diet, in
both males and females. Using a False Discovery Rate
with a significance level set at 0.05, we identified two
subsets of genes/ESTs that were differentially expressed
between males (n = 1803) and females (n = 1985) at
various stringency levels (absolute fold change > 2.0 >
A
B                                                                                              C
Figure 1 Diet effects on cardiac gene expression. A: Experimental design and statistical model. Eight samples per diet group were hybridized
onto Affymetrix 1.0ST GeneChip arrays. B: 2D heatmap of 6791 sex-specific cardiac genes (P < 0.01). C: 3D heatmap of standardized expression
values of DEGs with an FDR adjusted ANOVA p-value of <.01 for sex and diet.
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and Additional File 2 Table S2a and S2b). To better
understand the relevance of these sex-dimorphic genes
we used a program based on Gene Ontology (GO) cate-
gories of biological processes, molecular function and
cellular component. Additional File 3, Table S3 lists the
main functional GO categories of transcripts that were
differentially expressed between the sexes with a strin-
gency of ± 1.5-fold change in expression (P < 0.01).
DEGs were further characterized as being relatively up-
regulated either in males or in females. Increased tran-
scription of male genes in the “Biological processes”
category included genes involved in cellular macromole-
cule metabolism, anatomical structure development and
blood vessel development. These genes included Notch4,
interstitial matrix gene Col3a1 (type 3 collagen alpha 1),
fibulin 1 (Fbln1)a n di n t e g r i naV( Itgav). The predomi-
nant male-specific KEGG pathways included the
regulation of actin cytoskeleton and antigen processing
pathways (Additional File 3, Table S3). Conversely
female-specific transcription were enriched in the cate-
gories of cellular and metabolic processes, including
mitochondrial carbonic anhydrase 5b (Car5B), glu-
tathione S-transferase 4 (Gstm4)a n dm a g n e s i u mt r a n s -
porter 1 (Magt1). One KEGG-pathway for Cysteine and
methionine metabolism was also upregulated.
Chromosomal localization of differentially expressed
cardiac genes
To investigate a possible non-random chromosomal dis-
tribution of the DEGs, we used the Fisher exact test to
compare the frequencies of significant genes on each
chromosome against the total number of genes interro-
gated on each chromosome. Chromosomes 8,11 and Y
were enriched for male-biased genes whereas chromo-
somes 3,4,12 and X contained more female-biased genes
Table 1 Body characteristics
Control MSG TFA TFA+MSG P-Value
Body weight (g)
Male 29.58 ± 2.49 27.89 ± 1.83 34.38 ± 4.05 34.04 ± 5.18 0.500
Female 22.04 ± 1.81* 20.95 ± 1.7** 24.45 ± 2.33* 22.95 ± 1.97* 0.638
Weight change (%)
Male 58.69 ± 2.51
a 45.41 ± 1.83
b 79.72 ± 2.3
c 75.55 ± 3.18
c <.0001
Female 46.15 ± 2.13
a*** 37.11 ± 1.84
a** 61.7 ± 3.6
b*** 45.81 ± 2.8
a*** <.0001
Heart Weight (mg)
Male 127.4 ± 5.28
a 144 ± 5.15
ab 156.55 ± 3.34
b 155 ± 4.96
b <.0001
Female 115.2 ± 4.71
a 106.36 ± 4.34
a*** 144 ± 5.6
b 138.5 ± 6.12
b* <.0001
Heart: body weight ratio
Male 4.67 ± 0.2
a 5.27 ± 0.04
b 4.16 ± 0.13
a 4.27 ± 0.2
a <.0001
Female 5.38 ± 0.24
a* 2.33 ± 0.11
b*** 1.96 ± 0.12
b*** 5.46 ± 0.31
a** <.0001
Tg (mg/dL)
Male 80.93 ± 7.79
a 132.13 ± 12.63
b 98.6 ± 11.1
ab 112.7 ± 14.87
ab 0.024
Female 77.47 ± 5.75
a 106.13 ± 5.66
ab 123.75 ± 15.5
b 94 ± 11.3
ab 0.019
Fasting Insulin (μIU/ml)
Male 7.34 ± 0.43
a 12.31 ± 0.95
b 9.07 ± 0.64
ab 11.44 ± 1.73
ab 0.014
Female 7.34 ± 1.3 7.6 ± 1.72* 7.77 ± 1.08 8.9 ± 0.86 0.833
Fasting Glucose (mM)
Male 2.93 ± 0.59 2.97 ± 0.47 4.24 ± 1.05 3.33 ± 0.78 0.585
Female 2.41 ± 0.31 2.78 ± 0.3 3.27 ± 0.66 2.83 ± 0.36 0.579
HOMA-IR
Male 0.96 ± 0.08
a 1.62 ± 0.07
b 1.71 ± 0.14
b 1.7 ± 0.09
b <.0001
Female 0.79 ± 0.11
a 0.93 ± 0.08
ab*** 1.13 ± 0.07
b** 1.12 ± 0.07
ab*** 0.027
T-CHOL (mg/dL)
Male 119.2 ± 2.92
a 118 ± 1.45
a 124.67 ± 3.41
ab 131.67 ± 1.17
b 0.003
Female 121.6 ± 3.86 118 ± 3.97 130 ± 0.94 124 ± 2.97* 0.087
HDL-C (mg/dL)
Male 59.18 ± 5.34
a 69.95 ± 2.53
ab 80.8 ± 5.44
b 84.53 ± 3.26
b 0.002
Female 49.46 ± 3.61
a 49.42 ± 4.9
a** 72.53 ± 4.24
b 36.66 ± 6.57
a*** 0.001
abc Uncommon letters indicate difference in means between diet groups within a row (P-value <0.05).
Differences between genders within a diet group for each variable are denoted by *,** and *** for p-values <0.05, <0.01 & <0.001
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encoded on the Y chromosome which were male-speci-
fic (Sry, Ddx3y, Eif2s3y,a n dUty), and 86 female-biased
X-linked genes including Ace2, dystrophin, and several
transcription factors such as Tceal1, Tceal8 and Eif2s3x.
Trans-fat feeding induces sex-specific alterations in
cardiac gene expression
In order to identify the subset of genes and ESTs with a
fold difference of ± 1.5 or more within male or female
comparisons for mice fed the TFA diet versus control,
we used the results from a 2-way ANOVA model
described in the methods section. We identified 361
DEGs (148 upregulated and 213 downregulated) that
were responsive to diet in males; and approximately half
as many diet-responsive DEGs in females: 133 (80 upre-
gulated and 53 downregulated; P <0.01, Figure 3A,
Additional File 4, Table S4). Specifically, the Trans-fat
diet significantly downregulated the expression of many
male cardiac genes involved in the regulation of biologi-
cal processes, transcription and phosphorylation. Con-
versely females upregulated the expression of genes with
functional ontologies relating to binding, nitrogen com-
pound metabolism and ketone metabolism (Figure 3B-E,
P < 0.01). Significant male DEGs downregulated by TFA
consumption included key transcription modulator
sterol regulatory element binding factor 2 (Srebf2,3 . 5 -
fold, P < 0.01), transcription factors Mef2d (myocyte
enhancer factor 2D, 2-fold) and Gata4 (2-fold); vasocon-
strictive alpha-2b adrenergic receptor (2.8-fold); major
cardiac Na+ channel Scn5a (2-fold), heat shock tran-
scription factor 4 (Hsf4: 9.8-fold), calcium-regulating
enzyme phospholipase C δ (1.7-fold), and circadian
clock gene Per1 (period homolog 1: 2.6-fold). Signaling
molecules calcium/calmodulin-dependent protein kinase
kinase 1a (Camkk1) and mitogen-acrivated protein
kinase kinase 4 (Map2k4) expression were also halved in
male TFA mice. Conversely pro-hypertrophic Hdac2
(histone deacetylase 2), which represses Mef2 activity,
was upregulated in males and downregulated in females.
Other genes with this pattern of sex-dimorphic expres-
sion included plastin 3 (Pls3, 2.3-fold) and tachykinin 3
(Tacr3:2 . 4 - f o l d ) .I nb o t hs e x e s ,t h eT F Ad i e tl e dt o
increased expression of fatty acid oxidizing 3-hydroxy-3-
Figure 2 Chromosomal enrichment analysis shows sex-specific differences. Bar chart represents the chromosomal distribution of
differentially expressed genes in the male vs. female data. Light bars represent the significant genes on each chromosome; the number of
genes assayed on each chromosome is represented by the total height of each bar. Chromosomes that passed the test for enrichment by
Fisher’s exact test (P < 0.05) are symbolized as †, ‡, § for male vs. female, male biased and female biased gene subsets, respectively.
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Page 5 of 15methylglutaryl CoA synthase (Hmgcs2) and fructose
bisphosphatase 2 (Fbp2); however expression of TNF
superfamily member LIGHT/Tnfsf14 was increased 7-
fold in male Trans-fat hearts compared to control,
whereas it was only increase 2-fold in female Trans-fat
hearts. Diet-induced changes in female hearts were less
significant, with only 84 DEGs significantly up-regulated,
including progestin adipoQ receptor family member V
(Paqr5: 2.6-fold) and RAS guanyl releasing protein 2
(Rasgrp2, 2.2-fold). Enrichment analysis of functional
GO pathways within this subset revealed that females
exhibited a four-fold less down-regulation of cardiac
genes with classified biological function than males. We
next investigated the relationship between these genes
using Ingenuity Pathways Analysis (IPA). A network of
50 DEGs relating to cardiovascular disease and lipid
metabolism among others was identified as being signifi-
cantly affected by the TFA diet in cardiac tissue from
male mice (Figure 4A), whereas a network of 25 func-
tionally related genes involved in female lipid metabo-
lism and cardiovascular development is shown in Figure
4B (P < 0.01).
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B Upregulatedinmales
Metabolicprocess:HGMCS2FBP2SLC45A2GSTM4CAMK2BCYP20A1ATP10BCUL5CDKN2ANSMCE1FOXB2POLINDUFC1TATAHR
FBXO30PSAT1SRBD1PLS3 Aminemetabolicprocess:MTRFTCDITIH3PSAT1TAT
Nitrogencompoundmetabolicprocess:MTRHEBP1URODMCTS2PSAT1TPH1CNOT8LSM6
Geneexpression:HDAC2ENY2BMI1ETOHI1TAF1ARBM4CDKN2AZFP819SCG5FOXB2EXOSC8AHRGTF2H2MED31PARP14
Cellularresponsetostimulus:AHRGSTM4ING4CLSPNPOLINSMCE1CX3CR1MBD4TOPBP1GTF2H2
C Downregulatedinmales
Regulationofbiologicalprocess:MAP2K4HFS4KCNH1KCNH2EIF4EBP2CRY2HSF1SIK1SSBP3RELAVAMP2BAT2BAT3SPOCK2
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PXNTRIB1PER1PLCD1 BasichelixͲloopͲhelixtranscriptionfactor:TAL2TCFE3TCF3HEYL
Cellularmacromoleculemetabolicprocess:SREBP2CAMKK1CRY2BRD4ZDHHC3PKDCCPIM3IRF2BP1PROX1NEK11PURAHOXC10
CREB5SPOCK2UBP1SRRM2 Phosphorylation:BCKDKLIMK1MYLK3PKDCCPIM3ADORA1PXNTRIB1DYRK1BBRD4ND6STK38L
Regulationoftranscription:GATA4MEF2DNOTCH4JDP2ZFP42RORCTCFE3MED12LTAL2NR1H2FOXJ2FOXP4SF1CREB5SKIPROX1
PURAHOXB3HOXC10TRAF3IP1SP2HEYL VoltageͲgatedionchannel:SCN5AKCNH1KCNJ9SCN9AKCTD17KCNJ12KCNH2
Anatomicalstructuredevelopment:RORCPXNTAL2RGMASPRY1KATNA1KIRREL3LIMK1PCNTLDB1PROX1NTN1XIRP1DYRK1BPOLDIP2
BIN3STMN1MESP1NFICATP7B Apoptosis:TRAF3IP2ECE1TBRG4GRAMD4NTN1BAT3BAT2PURAPHLDA1
Cellcycle:PCNTKATNA1SF1NEK11 Cardiaccelldifferentiation:XIRP1GATA4PROX1
Viralmyocarditis:MYH14MYH8H2ͲM10.3DAG1H2ͲT10 Actinbindingcytoskeletalprotein:CORO1BACTL6BPXNXIRP1SYNPO2L
D Upregulatedinfemales
  Binding:HMGCS2FBP2PAQR5MYO7ATNFSF14TRPV5MS4A2POLIAIFM3DECR2MBD4CAMK2BFBN2TRIM25NEBEMILIN1
STAT2CLSPNSTK36SNRNP35GRIFINGRK4LUC7LPSAT1SRBD1PDZD3ATP7B
Nitrogencompoundmetabolism:FTCDMBD4AHRBRWD1ZFP819SDSGUCY1A2FOXB2SNRNP35GM7278ITIH3PSAT1TPH1SRBD1
Extracellularmatrixorganization:SERPINB5GFOD2EMILIN1 Enzymeregulatoractivity:RGL3TNFSF14RAPGEF3ITIH3PDZD3
AmmoniaͲlyaseactivity:SDSFTCD Caspaseregulatoractivity:AIFM3TNFSF14
ChemokinesignalingpathwaySTAT2CX3CR1GRK4 Cationtransport:CAPS2TRPV5CHRNB3KCNA5ATP7B
E DownregulatedInfemales
  ResponsetosƟmulus:PRG4SLC6A2H2Ͳ10HCKC230052I12RIKPDE3BCOTL1MDKTRAF3IP2PDE6APENKSCN9AABATCRY1
Multicellularresponsetostress:PENKSLC6A2SCN9A
Hydrolaseactivity:KDELR3LASS4PTPLBPDE3BIIGP1DOLPP1ADORA1SREBF22900062L11RIK
EndoplasmicReticulum:DE6ADUSP5PTPLBINPP5JPDE3BPNPLA3 Transaminase:BCAT1ABAT
Figure 3 Trans-fat feeding induces sex-specific alterations in cardiac gene expression. A: Bar chart indicates differences in numbers of
significant DEGs affected by the TFA diet in males and females, * P < 0.001 by Fisher’s exact test. B-E: Sex-specific differences in functional
ontology of genes deregulated by the TFA diet. Pie charts show the number of genes that were upregulated in males B; downregulated in
males C; upregulated in females D; downregulated in females E. Functional categories of DEGs were obtained using GO annotations from
DAVID.
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Figure 4 Trans-fat alters the expression of genes associated with cardiovascular disease and development in a sex-specific manner.
Functional relationship network representation of A: a subset of TFA-induced male DEGs relating to cardiovascular disease and lipid metabolism.
B: subset of TFA-induced female DEGs relating to cardiovascular development and lipid metabolism (P < 0.01, stringency ≥ ± 1.5-fold change in
expression).
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Page 7 of 15Monosodium Glutamate consumption alters cardiac gene
expression with sex-specific differences
A different pattern of gene expression was induced by
MSG feeding, which again showed significant sex-speci-
fic differences in cardiac gene expression. 2-way
ANOVA analysis revealed a subset of 153 male cardiac
DEGs (98 upregulated and 55 downregulated) which
were responsive to dietary MSG compared to control
diet, and 174 female DEGs (117 upregulated and 57
downregulated). (Figure 1C and Additional File 5, Table
S 5 ,P<0 . 0 1 ) .U n l i k eTrans-fat, MSG upregulated more
cardiac DEGs and down-regulated less. Genes/ESTs
u p r e g u l a t e di nm a l e sb u tn o tf e m a l e si nr e s p o n s et o
MSG included Ing4 (inhibitor of growth family member
4), glutathione S-transferase 4 and pancreatic lipase
(Pnlip). Transcripts enriched for female-biased expres-
sion included myosin 7a (Myo7a), Pdzd3 (PDZ domain
containing 3) and aldehyde dehydrogenase gene
Aldh1a3. Functional analysis of Gene Ontologies of
these subsets showed increased expression of male cellu-
lar and metabolic processes, whilst decreasing expres-
sion of phosphorylation-related DEGs (Additional File 6,
Table S6, P < 0.01). Conversely females upregulated
more genes/ESTs with developmental and anatomical
function ontologies. Genes/ESTs that were upregulated
in both sexes included ionotropic glutamate receptor
Grik3 (2.5-fold in males and 1.7-fold in females); nebulin
which regulates actin filament length (2.3-fold and 1.8-
fold in males and females respectively).
MSG alters Trans-fat induced cardiac gene expression
In order to address the question as to whether the addi-
tion of MSG to a Trans-fat diet could affect cardiac
gene expression, we next identified a subset of 338
DEGs which showed significant sex-dimorphism in
response to these two diets. 197 DEGs (117 upregulated
and 81 downregulated) in males showed significant
response to the inclusion of MSG in the Trans fat diet,
and 141 (60 upregulated, 81 downregulated) in females
(Figure 1C and Additional File 7 Table S7, P < 0.01). Of
note in both sexes, expression of lipogenic stearoyl-coA
desaturase 4 (Scd4) was upregulated in TFA+MSG diet
group hearts compared to TFA alone (1.6- and 1.4-fold
respectively, P < 0.01) and was accompanied by an
increase in Myosin H1, magnesium transporter Slc41a1,
and apoptosis-inducing BCL2-interacting killer (Bik).
Downregulated DEGs included fibrulin, sclerostin and
dystrophin, together with fatty acid-oxidizing enzymes
phospholipase A2 (Pla2g15) and aldehyde dehydrogen-
ase (Aldh1a3). Significant differentially expressed cardiac
transcripts in TFA + MSG-fed versus TFA-fed mice
were examined for enrichment of GO and KEGG classi-
fications (Additional File 8, Table S8). In males, major
functional GO categories included metabolism,
biosynthesis and transcription, whereas enrichment of
female DEGs upregulated by MSG feeding again fell
into the categories of developmental and anatomical
structural function.
Cellular positional mapping reveals sex-specific
differences in diet-deregulated gene expression
A final analysis of significant diet-induced deregulation
of cardiac gene expression between all diet combinations
co-analyzed yielded a cohort of 97 mapable genes which
were deregulated by all dietary manipulations only in
males (Figure 5 and Additional File 9, Table S9), and
half that number of genes which were only deregulated
in females (Figure 5 and Additional File 10, Table S10).
Interestingly in this male subset, expression of genes
previously demonstrated to be upregulated by TFA feed-
ing (Figure 5A) were downregulated in animals consum-
ing the MSG-enriched diets (Figure 5B and 5C, P <
0.01). Male-specific genes in this subset included stress-
related proteins Dnaja1 and Pdia4, together with phos-
phodiesterase 6a and histone H1e . Females displayed a
slightly divergent pattern (Figure 5D-F). Additionally 74
transcripts were identified as being significantly differen-
tially expressed in both sexes in response to all dietary
manipulations. Figure 6 shows a heatmap of a selection
based on functional relevance, together with a number
of X-linked and Y-linked diet-induced DEGs, P < 0.01
with a stringency of ± 1.5-fold change in expression.
Eighteen genes were randomly chosen for further ana-
lyzed by QRT PCR based on biological relevance. Pear-
son correlation coefficients between the microarray
analysis and QRT PCR were calculated. Ratios of
expressions between the diet comparisons calculated
from the microarray data set correlated well with the
ratio calculated from the real-time PCR data (Figure 7, r
= 0.718, P < 0.0001). A complete list of these genes and
PCR primers is given in Additional File 11, Table S11.
Discussion
Our results indicate that dietary manipulation prenatally,
a n do v e rt h ef i r s t8m o n t h sof life can markedly influ-
ence cardiac gene expression in a sex-specific manner.
Sexual dimorphism in gene expression exists even in the
healthy heart [7], and chromosome 4 has been shown to
have more female-biased differential cardiac gene
expression [9], whereas male-biased enrichment was
found in chromosomes 3 and 14. In addition to the X
and Y chromosomes which segregated as anticipated, we
found female-biased chromosomal enrichment on
mouse chromosomes 3, 4 and 12; and male-biased
expression on chromosomes 8 and 11. Interestingly, a
locus on murine chromosome 4 has been associated
with markers of the Metabolic Syndrome, including
body weight, insulin, leptin and triglyceride [31].
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Page 8 of 15The main outcome from our study was that Trans-fat
induced more than twice as many DEGs in males com-
pared to females, and downregulated four times as
many genes, including a number that have been impli-
cated in cellular pathways leading to hypertrophy such
as Gata4 and Mef2d [32]. Expression of Gata4,p r e -
viously identified as being of importance in stress
responsiveness [33], was halved in males in response to
the TFA diet. Gata4 regulates transcription of a large
number of cardiac genes via binding to the consensus
5’-WGATAR-3’ sequence, and is implicated in cardiac
muscle apoptosis, where under conditions of oxidative
stress Gata4 downregulation is preceded by MEK/ERK-
dependent phosphorylation [33]. Cardiac hypertrophy
and CHD are mediated by transcription factor integra-
tion of upstream stress signals, and Mef2d-deficient
mice have an attenuated hypertrophic response to car-
diac stress [34]. Mef2d activity is repressed by the his-
tone deacetylase Hdac2, which we found to be increased
in male TFA mice. Histone deacetylases are also regu-
lated by calmodulin and calmodulin kinase, and are
among the negative regulators of cardiac hypertrophy
which attenuates Mef2 transcriptional activity [32]. In
the present study, we found a reduction of expression of
Camkk1 and an increase in expression of Camk2b,s u g -
gesting that Trans-fat may deregulate both the calmodu-
lin kinase/Mef2/Hdac pathway and the PKC/MAPK/
GATA4 pathways of cardiac gene transcription.
Trans-fat feeding deregulated other stress-associated
genes in males including phospholipase C δ1, the main
cardiac isoform implicated in oxidative stress-induced
REDOX signaling [35], and LIGHT/Tnfsf14, demon-
strated to be upregulated in clinical and experimental
heart failure [36]. Additionally, key circadian clock gene
Per1 was decreased by more than half in the hearts of
male TFA-fed mice. Downregulation of Per1 by glucose
has been shown to be accompanied by changes in the
expression of genes involved in lipid metabolism, tran-
scription and cell cycle [37], such as sterol regulatory
element binding factor (Srebf2), hydroxy-3-methylglu-
taryl CoA synthase (Hmgcs) and stearoyl-coA desaturase
(Scd), all of which were differentially regulated by
Trans-fat in our study. Whilst it is known that Trans-fat
consumption is linked to cardiovascular disease [13], the
mechanism behind this is incompletely understood. Elai-
dic acid, the main TFA in partially hydrogenated vegeta-
ble shortening, incorporates into cardiac tissues [38];
and it has been suggested that TFAs are oxidized at a
Figure 5 Sexual dimorphism in global changes in cardiac gene transcription in response to all dietary manipulations co-analyzed.
Cellular positional mapping of genes deregulated by diet in males (A-C) and females (D-F) for either of the comparisons: control vs. TFA (A,D),
control vs. MSG (B,E), or TFA vs. TFA+MSG (C,F; P < 0.01).
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Page 9 of 15slower rate than cis-fatty acids [39], resulting in the
accumulation of reactive oxidation intermediates [40],
which could lead to oxidative stress and the activation
of the Gata4, Mefd2 and Hdac-associated transcriptional
pathways. Taken together, our results suggest that
Trans-fat feeding results in significant impairment of
transcriptional pathways relating to cellular stress, parti-
cularly in males. It has recently been shown that male
C57BL/6J mice are more vulnerable than females to the
impact of a high-fat diet in terms of ensuing weight gain
and deleterious metabolic peturbations [41]; and it is
therefore possible that the sex-differences in Trans fat
-induced cardiac gene expression seen in our study may
have contributed to the resultant increase in male
weight gain and heart: body ratio compared to females.
The MSG diet resulted in a different pattern of sexual
dimorphism in cardiac transcription, with fairly equal
numbers of DEGs being up- and down-regulated. How-
ever there were a number of genes which were overex-
pressed in males but not in females, and vice versa. The
functional categories of overexpressed genes differed
too, with females showing more enrichment of genes
associated with developmental processes for example,
whereas male upregulated transcripts were enriched for
cellular and metabolic function. Neonatal injections of
MSG result in smaller hearts with less DNA synthesiz-
ing activity [22]; and hypotension has been observed in
female, but not male rats treated neonatally with MSG
[42]. In our study, female hearts from MSG-diet group
mice weighed significantly less than male hearts, how-
ever an examination of genes deregulated in our MSG
mice did not provide many clues as to the mechanism
responsible for this apparent difference.
We have previously shown that MSG alters Trans fat
- i n d u c e dh e p a t i ca n da d i p o s et i s s u eg e n ee x p r e s s i o n
with the result that several key transcripts involved in ß-
oxidation of lipids were downregulated in TFA+MSG
treated mice [30]; and in our present study we found
that the combination of TFA+MSG decreased the
expression of several fatty acid-oxidizing enzymes such
as phospholipase A2 and aldehyde dehydrogenase,whilst
increasing the expression of lipogenic cardiac-specific
stearoyl-coA desaturase 4 (Scd4), previously shown to
be regulated by leptin and dietary factors [43].
When we compared cardiac gene transcription
between all dietary combinations co-analyzed, we again
found that more significant DEGs were induced in
males compared to females. Our analysis identified a
subset of over 100 transcripts which significantly chan-
ged only in male mice in response to diet, and approxi-
mately half this number of transcripts differentially
expressed in females only, and a similar number of
shared DEGs were common to both sexes. This suggests
that males may have a higher cardiac transcriptional
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Figure 6 Dietary manipulation results in deregulation of a
subset of genes shared by both sexes. A: Genes differentially
regulated in both with a fold change of ≥ ± 1.5 for either of the
comparisons control vs MSG, control vs TFA or TFA vs TFA+MSG. (P
< 0.01). B: A selection of X-linked and C: Y-linked cardiac genes
analyzed by microarray. Heatmap shows genes represented
horizontally and diet groups represented by the vertical rows: red
color signals genes with increased expression whilst blue indicated
a reduction of expression, with a stringency ≥ ± 1.5-fold change.
Collison et al. BMC Genomics 2011, 12:555
http://www.biomedcentral.com/1471-2164/12/555
Page 10 of 15response to dietary manipulation, and indeed greater
transcriptional response to exercise has previously been
demonstrated in males but not females [44]. Several the-
ories have been put forward as to this disparity, the car-
dioprotective effect of estrogen being one possibility
[45], especially in light of epidemiological data indicating
a lower incidence of female CHD, at least until meno-
pause, after which this dissimilarity declines. However,
this is unlikely to account for all the sex-specific differ-
ences observed, since after correcting for lifestyle fac-
tors, the discrepancy in CHD rates was reduced [46].
By using microarrays to analyze diet-induced cardiac
gene expression patterns, we have identified genes
which are differentially regulated and may play impor-
tant roles in the development of CHD associated with
Trans-fat consumption. However there are some issues
to consider when interpreting the results from the pre-
sent study. For the microarray experiments, we
employed a pooling design in order to reduce biological
variation, and to lower the costs associated with sample
size and chip availability [47]. In order to address a pos-
sible loss of sensitivity and an increase in the incidence
of false positives, we employed stringent criteria for the
identification of the diet-regulated DEGs. One limitation
of this study is the fact that these experiments were
only performed on C57Bl/6J mice of both sexes. It
would be advantageous but beyond the scope of the pre-
sent study, to ascertain whether similar results could be
obtained using a different genetic background, or possi-
bly a higher animal model.
Conclusion
We have found substantial evidence for sexual dimorph-
ism in response to dietary manipulation, with males
apparently showing the greater cardiac transcriptional
response. In particular, we found that Trans-fat feeding
in male mice resulted in deregulation of the expression
of genes involved in cellular stress pathways. Excessive
TFA consumption is believed to be a risk factor in
human heart disease, the incidence of which appears to
be higher in male patients. Our present observations
may provoke further studies which could result in sex-
specific medical intervention in the future.
Methods
Animals and diets
Our study animals were bred from C57BL/6J mice
obtained from The Jackson Laboratory (Maine, USA).
Female breeders were housed/caged and fed a stan-
dard chow diet until 6 weeks of age whereupon they
were placed on one of 4 different dietary regimens for
a period of 3 weeks prior to mating as described
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p-value=<0.0001
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Figure 7 Correlation of QRT-PCR and microarray data. Scatter plot shows Correlation of the ratios from the microarray and real-time PCR
data set. Genes that differed significantly (P < 0.01) in their regulation between the diet groups’ microarray analysis were selected and validated
with the same samples by real-time PCR analysis. Ratios of expressions between the diet comparisons calculated from the microarray data set
correlated well with the ratio calculated from the real-time PCR data (r = 0.718, P < 0.0001). A complete list of these genes is shown in
Additional File 11.
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Page 11 of 15previously [30]. The four diet regimens used in this
study were: [1] Standard Chow (Control diet)w i t h
ad lib drinking water. [2] Standard Chow, with ad lib
drinking water containing 0.64 g/L Monosodium Glu-
tamate (MSG diet). [3]Trans-fat diet of 20% (w/w)
Partially Hydrogenated Vegetable Shortening (Test
Diet #5C4M containing 8.68% w/w Trans fatty acids;
Test Diet Purina, USA), with ad lib drinking water
(TFA diet). [4]Trans-fat Diet #5C4M together with
ad lib drinking water containing 0.64 g/L Monoso-
dium Glutamate (TFA+MSG diet). See Table 2 for
diet composition. Following mating, the 4 groups of
dams were maintained on their respective diets
throughout the gestation and nursing period. Male
and female offspring (n = 20 per diet group) used in
the following experiments were weighed, weaned onto
the same diets and maintained on their respective
dietary regimens until they reached 32 weeks of age.
Average body weight was assessed at 6 and 32 weeks
of age; water intake and food consumption was
assessed at 6 and again at 28-30 weeks. The breeding
and care of the animals were in accordance with the
protocols approved by the Animal Care and Use
Committee of the King Faisal Specialist Hospital &
Research Centre.
Measurement of fasting serum cholesterols, triglyceride,
glucose, insulin and HOMA-IR levels
Serum Triglyceride (TG), T-CHOL and HDL-C concen-
trations were measured in overnight fasted 32-week old
mice using the Reflovet Plus instrument (Roche, F. Hoff-
mann-La Roche Ltd, Basel, Switzerland) according to
the manufacturer’s instructions. Overnight fasting blood
glucose was measured using the Ascensia Contour gluc-
ometer (Bayer HealthCare, IN, USA). Fasting Serum
insulin was measured using the ultrasensitive mouse
insulin ELISA kit from Mercodia (Uppsala, Sweden), as
described previously [30]. Homeostatic Model Assess-
ment Index (HOMA-IR) values, a measure of insulin
resistance, were calculated according to the established
formula: (fasting serum insulin μIU/ml) * (fasting serum
glucose mM)/22.5 [48].
RNA isolation
A n i m a l sw e r ee u t h a n i z e da t3 2w e e k so fa g eb yx y l a -
zine/ketamine intramuscular injection, and the hearts
were rapidly removed and rinsed in saline solution.
After weighing, the hearts were snap-frozen for RNA
extraction. Total RNA was prepared from snap-frozen
cardiac tissues from 32-week-old male and female mice
(n = 8 per diet group) using Qiagen RNeasy Kit (Quia-
gen, CA, USA) according to the manufacturer’s instruc-
tions and stored at -80°C. The integrity of total RNA
was measured using a 2100 Bioanalyzer instrument and
an RNA 6000 Nano LabChip assay (Agilent Technolo-
gies, CA, USA). RNA concentrations were determined
by absorption at 260-nm wavelength with an ND-1000
spectrometer (Nanodrop Technologies, DE, USA).
Gene expression analysis
Gene expression in these 64 samples was analyzed using
16 GeneChip (R) Mouse Gene 1.0 ST arrays represent-
ing 28,853 genes. We used 2 chips per diet group, and
applied pooled RNA from four mice per chip (see Figure
1 for design of the microarray experiments). Targets
were prepared and microarrays were processed as
described in the Affymetrix GeneChip Whole Transcript
Expression Analysis manual using commercially avail-
able Affymetrix GeneChip WT cDNA Synthesis Kit,
WT cDNA Amplification Kit, and WT Terminal Label-
ing Kit as per manufacturer’s instructions. Briefly,
approximately 200 ng of total RNA was used to synthe-
size double-stranded DNA with random hexamers
tagged with a T7 promoter sequence. The cDNA was
used as a template for in vitro transcription. In the sec-
ond cycle cDNA synthesis, random primers were used
in reverse transcription to convert the cRNA into sin-
gle-stranded DNA, which was fragmented, labeled, and
hybridized to the array for 16 hours using the Fluidics
450 station. Arrays were scanned using the Affymetrix
3000 7G scanner and GeneChip Operating Software ver-
sion 1.4 to produce.CEL intensity files. This software
also provided summary reports by which array QA
metrics were evaluated including average background,
average signal, and 3’/5’ expression ratios for spike-in
Table 2 Composition of experimental diets
Ingredients (g/100g dietary weight) Control MSG TFA TFA+MSG
Protein (%) 22.5 22.5 19.1 19.1
Carbohydrate (%) 64.2 64.2 37.7 37.7
Fat (%) (Ether extract) 5 5 28 28
Fiber 3 3 4.3 4.3
Vitamins, Minerals & Ash 5.3 5.3 10.9 10.9
Energy (kcal/g) 3.36 3.36 4.39 4.39
MSG (mg/Kg bodyweight) provided in drinking water 0 95.13 0 95.13
Caption: Table 2: Diet composition.
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Page 12 of 15controls, b-actin, and GAPDH. Microarray data was
deposited at the MIAME compliant NCBI gene expres-
sion hybridization array data repository (GEO: http://
ncbi.nlm.nih.gov/geo) under accession #GSE22881.
Data analysis
Morphological and biochemical data were analyzed
using one-way analysis of variance (ANOVA) followed
by Tukey’s test. Differences were considered significant
at P < 0.05. For identification of differentially expressed
genes (hereafter termed DEGs), microarray analysis was
performed using the Partek genomic suite software ver-
sion 6.3 (Partek, MO, USA) as previously described [30].
Probe set data were summarized and background
adjusted using the GC-Robust Multi-Array (GCRMA)
algorithm [49]. This method is used to reduce discre-
pancies in hybridization patterns that might result from
variables in target amplification, hybridization condi-
tions, staining or probe array lot. All data were normal-
ized using non-linear transformation termed Quantile
Normalization to improve the linearity, normality &
homoscedasticity of the data, which was further filtered
to remove noise and extreme expression values. A 2-
way analysis of variance (ANOVA) was performed to
detect significant differences among the diet groups and
sexes. Probability values were adjusted for multiple test-
ing using the False Discovery Rate (FDR) method [50].
This method uses a controlled FDR while adjusting for
testing simultaneously across multiple subgroup com-
parisons of sex and diet groups. Contrasts were included
in the model based on the comparison of interest. All
further sublists were created using genes that passed the
FDR adjusted ANOVA p-value as well as fold change
criteria. See Figure 1 for the design and statistical analy-
sis of the microarray experiments. All resultant genes
and expressed sequence tags (ESTs) meeting the criteria
for differential expression were ascribed genome-wide
significance using the Database for Annotation, Visuali-
zation, and Integrated Discovery (DAVID) annotation
[51]. Testing for chromosomal enrichment of the DEGs
was performed using the Fisher exact test. For detection
of Gene Ontology (http://www.geneontology.org) cate-
gories and Kyoto Encyclopedia of Genes and Genomes
(KEGG, http://www.kegg.com) pathways and pathway
analysis, with significant overrepresentation of tran-
scripts in diet groups compared to control. Heat maps
of the gene/ESTs expression data were also generated
using Partek. Networks of biologically related genes
were created using Ingenuity Pathways Analysis (IPA:
http://www.ingenuity.com). Sex-specific pathways identi-
fied from microarray analysis in the comparison of gene
expression in Trans-fat fed mice compared to control
were used to build literature-based male and female-spe-
cific pathways. In the two networks, genes or gene
products are represented as colored nodes, and biologi-
cal relationships between nodes are depicted as lines
connecting the individual nodes. P ≤ 0.01 was consid-
ered significant, with a stringency of ± 1.5-fold differ-
ence in expression levels.
Quantitative QPCR
Confirmation of microarray results was performed by
quantitative QPCR as previously described [30]. Total
RNA (2 μg) was reverse transcribed using Promega
Reverse Transcription system (Promega, WI, USA). Sub-
sequently, QPCR reactions were performed in triplicate
using SYBR-Green 1 master mix (Applied Biosystems)
and 10 ng cDNA as template. No template and no
reverse transcriptase controls were included and pro-
ducts were analysed by gel electrophoresis. Real time
RT-PCR values for each target gene were calculated as a
ratio of target gene expression level to the 18-S riboso-
mal expression level in the same specimen. Statistical
significance was assessed using a two-tailed t test
assuming unequal variance of the biological replicates.
Intron-spanning gene specific primers were designed
using Primer 3 software and sequences are provided in
Additional File 11. DEGs that differed significantly (P <
0.01) in their regulation between the diet groups’ micro-
array analysis were selected, based on their biological
relevance, and validated with the same samples by QRT-
PCR analysis. Ratios of expressions between the diet
comparisons were calculated from the microarray data
set and Pearson correlation analysis between the QRT-
PCR and microarray data were calculated.
Additional material
Additional File 1: Figure S1. Histology of cardiac tissue. A: transverse
section and B: longitudinal sections of hematoxin and eosin-stained
cardiac tissue from mice in control, MSG, TFA and TFA+MSG diet groups.
Scale is x790.
Additional file 2: Table S2a. Differentially expressed cardiac genes in
males compared to females (p ≤0.01) with a fold change of ≥ 1.5. Table
S2b. Differentially expressed cardiac genes in females compared to males
(p ≤0.01) with a fold change of ≥ 1.5.
Additional file 3: Table S3. Gene ontologies & pathways enriched for
differentially expressed genes comparing all males to all females.
Additional file 4: Table S4. Differentially expressed genes in either
males or females for the comparison TFA vs Control with respect to diet
and sex (P < 0.01) and fold change ≥ ± 1.5.
Additional file 5: Table S5. Differentially expressed genes in either
males or females for the comparison MSG vs Control with respect to diet
and sex (P < 0.01) and fold change ≥ ± 1.5.
Additional file 6: Table S6. Gene ontologies enriched for differentially
expressed genes comparing MSG to Control diet in males and females.
Additional file 7: Table S7. Differentially expressed genes in either
males or females for the comparison TFA+MSG vs TFA with respect to
diet and sex (P < 0.01) and fold Change ≥ ± 1.5.
Additional file 8: Table S8. Gene ontologies enriched for differentially
expressed genes comparing TFA+MSG to TFA diet in males and females.
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Page 13 of 15Additional file 9: Table S9. Intensities of genes/ESTs differentially
regulated only in males with a fold change of ≥ ± 1.5 for either of the
comparisons Control vs MSG, Control vs TFA, or TFA vs TFA+MSG.
Additional file 10: Table S10. Intensities of genes/ESTs differentially
regulated only in females with a fold change of ≥ ± 1.5 for either of the
comparisons Control vs MSG, Control vs TFA, or TFA vs TFA+MSG.
Additional File 11: Table S11. Primers for genes selected for
confirmatory QRT-PCRs.
Abbreviations
KEGG: Kyoto Encyclopedia of Genes and Genome; MSG: Monosodium
Glutamate; TFA: Trans Fatty Acid; DEGs: Differentially Expressed Genes, ESTs:
Expressed Sequence Tags; GO:Gene Ontology;
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